Infusion Devices Market Demand Driven by Healthcare Innovation

United States of America – March 10, 2026 – According to The Insight Partners, the infusion devices market is experiencing robust growth as healthcare systems worldwide embrace advanced technologies for precise medication delivery and chronic disease management. According to The Insight Partners' comprehensive market analysis, the infusion devices market is projected to expand from US$ 13.73 billion in 2023 to US$ 23.08 billion by 2031, registering a compound annual growth rate of 6.7% during the forecast period. This sustained expansion reflects the critical role these devices play in modern healthcare, particularly in managing diabetes, cancer, pain, and other chronic conditions requiring controlled medication administration.

Get the sample request - https://www.theinsightpartners.com/sample/TIPRE00039332

Understanding Infusion Devices and Their Clinical Importance

Infusion devices encompass sophisticated medical equipment designed to deliver fluids, medications, nutrients, and blood products into patients' bodies in controlled, precise amounts. The market comprises two primary product categories: infusion pumps and infusion sets. Infusion pumps include volumetric pumps, syringe pumps, insulin pumps, patient-controlled analgesia (PCA) pumps, enteral pumps, implantable pumps, and elastomeric pumps, each serving specific clinical applications. Infusion sets, divided into vented and non-vented varieties, provide the critical connection between medication sources and patients' vascular systems. These technologies enable healthcare providers to deliver treatments with accuracy impossible through manual administration, reducing medication errors and improving patient outcomes.

Rising Cancer Prevalence Driving Market Demand

One of the most significant forces propelling market growth is the escalating global cancer burden. Cancer treatment protocols heavily rely on infusion therapy for chemotherapy administration, supportive care, and symptom management. According to the National Cancer Institute, breast, lung, colorectal, and prostate cancers account for nearly 50% of all new cancer diagnoses in the United States, while colorectal, pancreatic, lung, and breast cancers are responsible for approximately half of all cancer-related deaths. This mounting disease burden creates sustained demand for infusion devices capable of delivering precise chemotherapy dosages over extended periods while minimizing side effects and enabling outpatient treatment options.

Aging Population Fueling Healthcare Needs

The rapidly expanding geriatric population represents another critical market driver. The U.S. Census Bureau projects that the number of Americans aged 65 and above will increase from 58 million in 2022 to 82 million by 2050—a 47% surge. The World Health Organization estimates that by 2030, one in six people globally will be 60 years or older, with this demographic reaching 2.1 billion by 2050. Older adults frequently require infusion therapy for multiple conditions including immune support, pain management, hydration, and nutritional supplementation. Infusion devices deliver immune-boosting nutrients such as vitamin C, zinc, and glutathione directly into the bloodstream while providing effective chronic pain management—addressing two major quality-of-life concerns among seniors.

Technological Advancements and Strategic Initiatives

Innovation is reshaping the infusion devices landscape. Recent developments highlight the industry's commitment to enhancing safety, connectivity, and user experience. Mackenzie Health's launch of BD Alaris EMR Interoperability in Canada enables two-way communication between IV pumps and electronic medical records, eliminating manual programming and reducing administration errors. Medtronic's Extended infusion set, approved for up to seven-day wear, represents a breakthrough in insulin pump therapy convenience. Fresenius Kabi's wireless Agilia Connect Infusion System, cleared following new TIR101 standards, demonstrates the integration of wireless technology with advanced safety software.

Regional Dynamics and Market Leadership

North America dominates the global market, driven by high chronic disease prevalence, advanced healthcare infrastructure, and strong regulatory frameworks supporting innovation. However, Asia Pacific is emerging as the fastest-growing region. China alone has witnessed diabetes prevalence among adults increase to 13% in 2021, affecting 140.86 million people. MicroTech Medical's Equil patch insulin pump captured significant market share in China through an extensive distribution network covering over 800 hospitals, with revenues surging 111% year-over-year.

Future Outlook

As chronic diseases continue rising globally and healthcare systems prioritize precision medicine, the infusion devices market stands positioned for sustained growth, supported by continuous technological innovation, expanding homecare applications, and increasing adoption across diverse clinical settings worldwide.

2 Pressure Infusion Devices Market

About Us:

The Insight Partners is among the leading market research and consulting firms in the world. We take pride in delivering exclusive reports along with sophisticated strategic and tactical insights into the industry. Reports are generated through a combination of primary and secondary research, solely aimed at giving our clientele a knowledge-based insight into the market and domain. This is done to assist clients in making wiser business decisions. A holistic perspective in every study undertaken forms an integral part of our research methodology and makes the report unique and reliable.

Contact Us: If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Ankit Mathur

E-mail: [email protected]

Phone: +1-646-491-9876

Also Available in: Korean German Japanese French Chinese Italian Spanish